


| Ingredients | Product Name | Formulation | Report Category | Report Date |
| Acyclovir | Cytabic Oral Adhesive Tablet (Acyclovir) | Patch | Supply Discontinuation | 2026-03-05 |
| Allergen Extract | Novohygene Depot Maintenance Treatment A | Solution Injection | Supply Discontinuation | 2026-03-04 |
| Allergen Extract | Novoheligene Depot Initial Treatment A | Solution Injection | Supply Discontinuation | 2026-03-04 |
| Milnacipran Hydrochloride | Excel Capsule 12.5 milligram (Milnacipran hydrochloride) | Hard Capsule, Powder | Supply Discontinuation | 2026-03-04 |
| Mitoxantrone Hydrochloride | Mitron Injection (Mitoxantrone Hydrochloride) | Solution Injection | Supply Discontinuation | 2026-02-27 |
| Meglumine, Sodium Hydroxide, Amidotrizoic Acid | Gastrografin | Oral Solution | Supply Discontinuation | 2026-02-26 |
| Phentermine Hydrochloride | Phentermine Extended-Release Capsules 30 milligrams (Phentermine Hydrochloride) | Extended-Release Capsule, Pellet | Supply Shortage | 2026-02-25 |
| Diazepam | Daewon Diazepam Tablets 2 Milligrams (Export Name: Diazepam Tablets 2 Milligrams) (Export Name 2: Trezcon Tablets 2 Milligrams) | Najeong | Supply Discontinuation | 2026-02-20 |
| Hydrogen Peroxide, Benzoyl, Clindamycin Phosphate | Duac Gel 5% | Dermatological gel | Supply Discontinuation | 2026-02-19 |
| Microlanzapine | Zyprexa Zydis Extended-Release Tablets 10 milligrams (olanzapine) | Oral Disintegrating Tablet | Supply Shortage | 2026-02-13 |
| Microlanzapine | Zyprexa Zyidis Extended-Release Tablets 5 milligrams (olanzapine) | Oral Disintegrating Tablet | Supply Shortage | 2026-02-13 |
| Bacillus licheniformis, Calcium Pantothenate | Zangierak Capsule | Hard Capsule, Powder | Supply Discontinuation | 2026-02-12 |
| Bemiparin Sodium | Zyber 2500 IU AntiXa/0.2 mL (Sodium Bemiparin) | Solution Injection | Supply Discontinuation | 2026-02-10 |
| Bemiparin Sodium | Zyber Injection 3500 IU AntiXa/0.2 mL (Sodium Bemifarin) | Solution Injection | Supply Discontinuation | 2026-02-10 |
| Pimozide | Myeongin Pimozide Tablets 4 Milligrams | Najeong | Supply Discontinuation | 2026-02-04 |
| Nimodipine | Samjin Nimodipine Injection 10 Milligrams (Export Name: Moditoplinjection) | Solution Injection | Supply Shortage | 2026-02-03 |
| Cisplatin | Unistin Injection 0.5mg/mL (Cisplatin) (Export Name: Newplatin Inj. 0.5mg/mL, Cytosplat Inj. 0.5mg/mL, Nextin Inj. 0.5mg/mL, KU Cisplatin Inj. 0.5mg/mL | Solution Injection | Supply Discontinuation | 2026-02-03 |
| Cisplatin | Unistin Injection 1mg/mL (Cisplatin) (Export Name: Newplatin Inj. 1mg/mL, Cytosplat Inj. 1mg/mL, Nextin Inj. 1mg/mL, Kupunistin Inj. 1mg/mL, KU Cisplatin Inj. 50mg/50mL) | Solution Injection | Supply Discontinuation | 2026-02-03 |
| Isosorbide Dinitrate Sustained-Release Granules | Bukwang Isomac Sustained-Release Capsule (Isosorbide Dinitrate Sustained-Release Granules) | Extended-Release Capsule, Pellet | Supply Discontinuation | 2026-02-02 |
| Sodium Phenytoin | Serebix Injection (Sodium Phenytoin) | Solution Injection | Supply Discontinuation | 2026-01-30 |
| Sodium Phenytoin | Serebix Injection (Sodium Phenytoin) | Solution Injection | Supply Discontinuation | 2026-01-30 |
| Polysaccharide Iron Complex | Hemonia Capsule (Polysaccharide Iron Complex) | Hard Capsule, Powder | Supply Discontinuation | 2026-01-30 |
| Fluvastatin Sodium | Rescol XL Extended-Release Tablets (Fluvastatin Sodium) | Extended-Release Film-Coated Tablets | Supply Discontinuation | 2026-01-29 |
| Talazoparip Tosylate | Talzena Capsule 1 Milligram (Talazoparib Tosylate) | Hard Capsule, Powder | Supply Discontinuation | 2026-01-28 |
| Haloperidol Decanoate | Haloperidol Decanoate Injection (Haloperidol Decanoate) | Solution Injection | Supply Shortage | 2026-01-28 |
| Bacillus licheniformis, Calcium Pantothenate | Biscanbisan | Powder | Supply Discontinuation | 2026-01-28 |
| Human Papillomavirus-16 L1 (Host: Trichoplusia ni Hi-5 Rix4446, Vector: rBaculo4449), Human Papillomavirus-18 L1 (Host: Trichoplusia ni Hi-5 Rix4446, Vector: rBaculo4450) | Suvarix Prefilled Syringe [Human Papillomavirus Vaccine (Recombinant)] | Suspension for Injection | Supply Discontinuation | 2026-01-23 |
| Sodium Bicarbonate | Daewon Sodium Bicarbonate Injection (8.4%) | Solution Injection | Supply Shortage | 2026-01-22 |
| Ketorolac Tromethamine | Acuveil Eye Drops 0.45% (Ketorolac Tromethamine) (Single-Use) | Eye Drops | Supply Shortage | 2026-01-21 |
| Vinblastine Sulfate | Vinblastine Sulfate Injection | Freeze-Dried Powder for Solution Injection | Supply Discontinuation | 2026-01-15 |
| Dacarbazine | DTIC Injection 200 Milligrams (Dacarbazine) (Export Name: DTIC-VHB for injection, Duticin for injection) | Freeze-Dried Powder for Solution Injection | Supply Discontinuation | 2026-01-15 |
| Mequitazine | Primaran Tablets (Mequitazine) | Najeong | Supply Discontinuation | 2026-01-15 |
| Dilazep Hydrochloride Hydrate | Bukwang Comelian Tablets 50 milligrams (Dilazep Hydrochloride Hydrate) | Film-coated Tablet | Supply Discontinuation | 2026-01-15 |
| Dacarbazine | DTIC Injection (Dacarbazine) (Export Name: DTIC-VHB for injection 100mg) | Freeze-Dried Powder for Solution Injection | Supply Discontinuation | 2026-01-15 |
| Deferasirox | Exzide Film-Coated Tablets 180 milligrams (Deferasirox) | Film-coated Tablet | Supply Shortage | 2026-01-14 |
| Dexketoprofen Trometamol | Keral Injection (Dexketoprofen Trometamol) | Solution Injection | Supply Discontinuation | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 80mg (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 10 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 20mg (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 40mg (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Nimodipine | Cerebonal Tablets (Nimodipine) | Film-coated Tablet | Supply Discontinuation | 2026-01-05 |
| Nalbuphine Hydrochloride | Hanar Haloperidol Hydrochloride Injection 10 Milligrams | Solution Injection | Supply Discontinuation | 2026-01-05 |
| Active ingredients | Status | Update | Specialty |
| cefuroxime axetil | Stock shortage | 06/03/2026 | Zinnat 125 mg/5 mL for children and infants, granules for oral suspension in bottle |
| methylprednisolone (hydrogen succinate) | Supply tension | 05/03/2026 | Methylprednisolone Viatris 500 mg, powder for solution for injection (IM-IV) |
| potassium canrenoate/trometamol | Discontinuation | 05/03/2026 | Soludactone 100 mg and 200 mg, lyophilisate and solution for parenteral use |
| methylprednisolone (hydrogen succinate) | Supply tension | 05/03/2026 | Methylprednisolone Viatris 40 mg, powder for solution for injection (IM-IV) |
| lithium (carbonate) | Supply tension | 05/03/2026 | Teralithe 250 mg, breakable tablet |
| methylprednisolone (hydrogen succinate) | Supply tension | 05/03/2026 | Methylprednisolone Viatris 120 mg, powder for solution for injection (IM-IV) |
| piperacillin sodium | Supply tension | 04/03/2026 | Piperacillin Panpharma 4 g, powder for solution for injection (I.M., I.V.) |
| fluorouracil | Supply tension | 02/03/2026 | Fluorouracil Accord 50 mg/mL, solution for dilution for infusion, 5 mL, 20 mL, and 100 mL vials |
| fluorouracil | Supply tension | 02/03/2026 | Fluorouracil Pfizer 50 mg/mL, solution for dilution for infusion – 20 mL and 100 mL vials |
| Active ingredients |
| Date of last message | Type of reason | AM designation | |
| Ritonavir | Change notification | 06.03.2026 | Other | Norvir 100 mg film-coated tablets – OP30 | |
| Levetiracetam | Initial report | 06.03.2026 | Other | LEVETIRACETAM BASICS 1000 mg film-coated tablets | |
| Levetiracetam | Initial report | 06.03.2026 | Other | LEVETIRACETAM BASICS 250 mg film-coated tablets | |
| Fluconazole | Initial report | 06.03.2026 | Other | FLUCONAZOLE BASICS 150 mg capsules | |
| Candesartan cilexetil | Change notification | 06.03.2026 | Other | CANDESARTAN BASICS 16 mg tablets | |
| Esomeprazole hemimagnesium | Change notification | 06.03.2026 | Production problem | ESOMEPRAZOLE BASICS 20 mg gastro-resistant hard capsules | |
| Rifampicin | Change notification | 06.03.2026 | Production problem | EREMFAT 450 mg | |
| Pregabalin | Initial report | 06.03.2026 | Other | LYRICA 25 mg hard capsules – OP112(2×56) | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 06.03.2026 | Other | Atorvastatin Micro Labs 30 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 06.03.2026 | Other | Atorvastatin Micro Labs 80 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 06.03.2026 | Other | Atorvastatin Micro Labs 80 mg film-coated tablets | |
| Primidone | Change notification | 05.03.2026 | Other | Primidone Holsten | |
| Hydrocortisone | Initial report | 05.03.2026 | Production problem | Efmody | |
| Colistimethate sodium | Change notification | 05.03.2026 | Production problem | Colistin CF | |
| Nitrendipine | Change notification | 05.03.2026 | Other | Nitrendipine AbZ 20 mg tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.03.2026 | Other | Quetiapine AbZ 150 mg prolonged-release tablets | |
| Ribavirin | Change notification | 05.03.2026 | Other | Ribavirin-ratiopharm 400 mg film-coated tablets | |
| Ribavirin | Change notification | 05.03.2026 | Production problem | Ribavirin-ratiopharm 200 mg film-coated tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.03.2026 | Production problem | Quetiapine HEXAL 400 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.03.2026 | Production problem | Quetiapine HEXAL 200 mg prolonged-release tablets | |
| Propranolol hydrochloride | Change notification | 05.03.2026 | Other | Propra-ratiopharm 10 mg film-coated tablets | |
| Nitrendipine | Change notification | 05.03.2026 | Other | Nitrendipine-ratiopharm 10 mg tablets | |
| Atomoxetine hydrochloride | Change notification | 05.03.2026 | Other | Atomoxe – 1 A Pharma 18 mg hard capsules | |
| Methylphenidate hydrochloride | Change notification | 05.03.2026 | Other | Methylphenidate-ratiopharm 30 mg modified-release hard capsules | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.03.2026 | Production problem | Quetiapine HEXAL 150 mg prolonged-release tablets | |
| Cinacalcet hydrochloride | Change notification | 05.03.2026 | Other | Cinacalcet-ratiopharm 30 mg film-coated tablets | |
| Doxepin hydrochloride (Ph.Eur.) | Change notification | 05.03.2026 | Other | Doxepin-ratiopharm 25 mg film-coated tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.03.2026 | Production problem | Quetiapine HEXAL 300 mg prolonged-release tablets | |
| Pramipexole dihydrochloride monohydrate | Change notification | 05.03.2026 | Other | Pramipexole – 1 A Pharma 0.26 mg prolonged-release tablets | |
| Thioctic acid trometamol salt (1:1) | Change notification | 05.03.2026 | Other | Thioctacid 600 T | |
| Clonidine hydrochloride | Change notification | 05.03.2026 | Other | Clonidine-ratiopharm 300 | |
| Clonidine hydrochloride | Change notification | 05.03.2026 | Other | Clonidine-ratiopharm 150 | |
| Clonidine hydrochloride | Change notification | 05.03.2026 | Other | Clonidine-ratiopharm 75 | |
| Amlodipine besylate; Hydrochlorothiazide; Valsartan | Change notification | 05.03.2026 | Other | Amlodipine/Valsartan/HCT Holsten 10 mg/160 mg/12.5 mg film-coated tablets | |
| Carmustine | Initial report | 04.03.2026 | Production problem | Carmustine-ratiopharm | |
| Busulfan | Initial report | 04.03.2026 | Production problem | Busulfan-ratiopharm 6 mg/ml concentrate for solution for infusion | |
| Fluorouracil | Change notification | 04.03.2026 | Other | Fluorouracil PhaRes 50 mg/ml solution for injection | |
| Deferasirox | Change notification | 04.03.2026 | Other | Deferasirox Mylan 180 mg film-coated tablets | |
| Nitrendipine | Change notification | 04.03.2026 | Other | Nitrendipine AL 10 | |
| Nitrendipine | Change notification | 04.03.2026 | Other | Nitrendipine AL 20 | |
| Rivaroxaban | Initial report | 03.03.2026 | Other | Xarelto 1 mg/ml granules for oral suspension | |
| Aflibercept | Change notification | 03.03.2026 | Other | MYNZEPLI | |
| Primidone | Change notification | 03.03.2026 | Production problem | Mylepsinum | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 03.03.2026 | Other | Quetiapine AL 50 mg prolonged-release tablets | |
| Etoricoxib | Initial report | 03.03.2026 | Other | Etorican 120 mg film-coated tablets | |
| Terazosin hydrochloride dihydrate | Change notification | 03.03.2026 | Other | Heitrin 2 mg | |
| Oxycodone hydrochloride (Ph.Eur.) | Change notification | 03.03.2026 | Other | Oxycan uno 10 mg prolonged-release tablets | |
| Sumatriptan succinate | Change notification | 03.03.2026 | Production problem | MIGRAPEN 3 mg/0.5 ml solution for injection in a pre-filled pen | |
| Tirofiban hydrochloride monohydrate | Initial report | 03.03.2026 | Production problem | Aggrastat 250 micrograms/ml concentrate for solution for infusion | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 03.03.2026 | Other | Quetiapine hormosan 200 mg prolonged-release tablets | |
| Tobramycin | Initial report | 03.03.2026 | Other | TOBI Podhaler 28 mg hard capsules with powder for inhalation – OP224(4×56) | |
| Atomoxetine hydrochloride | Change notification | 03.03.2026 | Production problem | Atomoxetine beta 80 mg hard capsules | |
| Fluoxetine hydrochloride | Change notification | 03.03.2026 | Other | Fluoxetine beta 20 | |
| Epinephrine/adrenaline | Change notification | 03.03.2026 | Production problem | Anapen 500 micrograms solution for injection | |
| Hydrochlorothiazide; losartan potassium | Change notification | 03.03.2026 | Other | LosarHCT-Denk 50 mg/12.5 mg film-coated tablets | |
| Phenylephrine hydrochloride | Change notification | 03.03.2026 | Production problem | Neosynephrine-POS 5% | |
| Proxymetacaine hydrochloride | Change notification | 03.03.2026 | Production problem | Proparacaine-POS 0.5% | |
| Human immunoglobulin G | Initial report | 02.03.2026 | Production problem | IQYMUNE | |
| Human immunoglobulin G | Initial report | 02.03.2026 | Production problem | IQYMUNE | |
| Carbamazepine | Change notification | 02.03.2026 | Other | Timonil Syrup | |
| Fenoterol hydrobromide | Initial report | 02.03.2026 | Production problem | Intrapartum obstetricians | |
| Etanercept | Change notification | 02.03.2026 | Other | Nepexto 50 mg solution for injection in a pre-filled syringe |
Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
| candesartan cilexetil | Tablet, uncoated | 4 mg | Anticipated | Available | Manufacturing | 8/03/2026 |
| paclitaxel | Injection, powder for | 100 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/03/2026 |
| nitrofurantoin | Capsule, hard | 100 mg | Resolved | Available | Unexpected increase in consumer demand | 8/03/2026 |
| candesartan cilexetil~hydrochlorothiazide | Tablet, uncoated | 16 mg~12.5 mg | Anticipated | Available | Manufacturing | 8/03/2026 |
| trandolapril | Capsule | 4 mg | Current | Unavailable | Manufacturing | 6/03/2026 |
| Interferon gamma1b | Injection, solution | 4 million IU/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 6/03/2026 |
| tadalafil | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 6/03/2026 |
| phenobarbital sodium | Injection, solution | 219 mg/mL | Anticipated | Available | Manufacturing | 6/03/2026 |
| gliclazide | Tablet, uncoated | 80 mg | Current | Limited Availability | Manufacturing | 6/03/2026 |
| trandolapril | Capsule | 2 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 6/03/2026 |
| atracurium besilate | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 6/03/2026 |
| atorvastatin calcium trihydrate~amlodipine besilate | Tablet, film coated | 21.688 mg~13.88 mg | Anticipated | Available | Manufacturing | 6/03/2026 |
| atorvastatin calcium trihydrate~amlodipine besilate | Tablet, film coated | 21.688 mg~6.94 mg | Anticipated | Available | Manufacturing | 6/03/2026 |
| lamotrigine | Tablet, uncoated | 200 mg | Current | Unavailable | Manufacturing | 6/03/2026 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Current | Limited Availability | Manufacturing | 6/03/2026 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 6.94 mg~86.751 mg | Anticipated | Available | Manufacturing | 6/03/2026 |
| risperidone | Tablet, film coated | 2 mg | Current | Limited Availability | Manufacturing | 6/03/2026 |
| bupivacaine hydrochloride | Injection, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 6/03/2026 |
| carbidopa monohydrate~entacapone~levodopa | Tablet, film coated | 54.1 mg~200 mg~200 mg | Resolved | Available | Manufacturing | 6/03/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.38 mg | Current | Unavailable | Manufacturing | 6/03/2026 |
| lamotrigine | Tablet, uncoated | 200 mg | Anticipated | Available | Manufacturing | 6/03/2026 |
| rosuvastatin calcium | Tablet, film coated | 20.84 mg | Current | Limited Availability | Manufacturing | 6/03/2026 |
| lamotrigine | Tablet | 25 mg | Current | Unavailable | Manufacturing | 6/03/2026 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Current | Limited Availability | Manufacturing | 6/03/2026 |
| lidocaine hydrochloride | Injection, solution | 10 mg/mL | Current | Limited Availability | Manufacturing | 6/03/2026 |
| hydroxocobalamin chloride | Injection, solution | 1 mg/mL | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 6/03/2026 |
| latanoprost | Eye Drops, solution | .05 mg/mL | Current | Unavailable | Manufacturing | 6/03/2026 |
| desmopressin acetate | Spray, solution | .1 mg/mL | Current | Unavailable | Product recall | 6/03/2026 |
| pregabalin | Capsule, hard | 25 mg | Current | Unavailable | Manufacturing | 6/03/2026 |
| amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil | Tablet, film coated | 13.9 mg~12.5 mg~40 mg | Anticipated | Available | Manufacturing | 6/03/2026 |
| rosuvastatin calcium | Tablet, film coated | 20.84 mg | Current | Unavailable | Unexpected increase in consumer demand | 6/03/2026 |
| lacosamide | Tablet, film coated | 50 mg | Current | Limited Availability | Manufacturing | 6/03/2026 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 13.88 mg~43.376 mg | Anticipated | Available | Manufacturing | 6/03/2026 |
| beclometasone dipropionate | Inhalation, pressurised | .05 mg/actuation | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 6/03/2026 |
| cinacalcet hydrochloride | Tablet, film coated | 99 mg | Current | Unavailable | Manufacturing | 6/03/2026 |
| flunitrazepam | Tablet, film coated | 1 mg | Resolved | Available | Manufacturing | 6/03/2026 |
| clevidipine | Injection, emulsion | 25 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 6/03/2026 |
| trandolapril | Capsule | 1 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 6/03/2026 |
| pravastatin sodium | Tablet, uncoated | 20 mg | Anticipated | Available | Manufacturing | 6/03/2026 |
| cisatracurium besilate | Injection, solution | 6.7 mg/mL | Current | Unavailable | Manufacturing | 6/03/2026 |
| lamotrigine | Tablet | 200 mg | Current | Unavailable | Manufacturing | 6/03/2026 |
| ezetimibe~simvastatin | Tablet | 10 mg~10 mg | Current | Unavailable | Manufacturing | 5/03/2026 |
| ezetimibe~simvastatin | Tablet | 10 mg~40 mg | Current | Unavailable | Manufacturing | 5/03/2026 |
| oxycodone hydrochloride | Tablet, uncoated | 5 mg | Current | Limited Availability | Manufacturing | 5/03/2026 |
| formoterol fumarate | Inhalation, powder for | 12 microgram | Current | Unavailable | Manufacturing | 5/03/2026 |
| naproxen | Tablet | 500 mg | Anticipated | Available | Manufacturing | 5/03/2026 |
| amidotrizoate meglumine~sodium amidotrizoate | Injection, solution | 260 mg/mL~40 mg/mL | Current | Unavailable | Manufacturing | 5/03/2026 |
| amidotrizoate meglumine~sodium amidotrizoate | Injection, intravenous infusion | 260 mg/mL~40 mg/mL | Current | Unavailable | Manufacturing | 5/03/2026 |
| sodium amidotrizoate~amidotrizoate meglumine | Oral Liquid, solution | 10 g~66 g | Current | Unavailable | Manufacturing | 5/03/2026 |
| venlafaxine | Capsule, modified release | 150 mg | Current | Unavailable | Manufacturing | 5/03/2026 |
| temozolomide | Capsule, hard | 5 mg | Current | Limited Availability | Manufacturing | 5/03/2026 |
| simvastatin~ezetimibe | Tablet | 20 mg~10 mg | Current | Unavailable | Manufacturing | 5/03/2026 |
| temozolomide | Capsule, hard | 140 mg | Current | Limited Availability | Manufacturing | 5/03/2026 |
| ezetimibe~simvastatin | Tablet | 10 mg~80 mg | Current | Limited Availability | Manufacturing | 5/03/2026 |
| levothyroxine sodium | Tablet | .075 mg | Current | Unavailable | Manufacturing | 4/03/2026 |
| risperidone | Tablet, film coated | 3 mg | Current | Unavailable | Manufacturing | 4/03/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 21.69 mg | Current | Unavailable | Manufacturing | 4/03/2026 |
| Pegvisomant | Injection, powder for | 10 mg | Current | Limited Availability | Manufacturing | 4/03/2026 |
| galantamine hydrobromide | Capsule, modified release | 10.256 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 4/03/2026 |
| desvenlafaxine | Tablet, modified release | 100 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 4/03/2026 |
| pemetrexed disodium | Injection, powder for | 110.28 mg | Current | Unavailable | Manufacturing | 4/03/2026 |
| pemetrexed disodium | Injection, powder for | 1102.8 mg | Current | Unavailable | Manufacturing | 4/03/2026 |
| diltiazem hydrochloride | Capsule, modified release | 360 mg | Current | Unavailable | Manufacturing | 4/03/2026 |
| diltiazem hydrochloride | Capsule, modified release | 360 mg | Current | Unavailable | Manufacturing | 4/03/2026 |
| lidocaine hydrochloride | Injection, concentrated | 100 mg/mL | Anticipated | Available | Manufacturing | 4/03/2026 |
| desvenlafaxine | Tablet, modified release | 50 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 4/03/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.76 mg | Resolved | Available | Manufacturing | 4/03/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.38 mg | Current | Unavailable | Manufacturing | 4/03/2026 |
| tobramycin | Capsule, hard | 28 mg | Resolved | Available | Manufacturing | 4/03/2026 |
| oxycodone hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 4/03/2026 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 4/03/2026 |
| cisatracurium besilate | Injection, solution | 14.07 mg | Current | Limited Availability | Manufacturing | 4/03/2026 |
| desvenlafaxine | Tablet, modified release | 100 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 4/03/2026 |
| desvenlafaxine | Tablet, modified release | 50 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 4/03/2026 |
| dinoprostone | Gel | .3333 mg/g | Current | Unavailable | Manufacturing | 3/03/2026 |
| amisulpride | Tablet, uncoated | 400 mg | Current | Limited Availability | Manufacturing | 3/03/2026 |
| montelukast sodium | Tablet | 10.4 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 3/03/2026 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Unavailable | Manufacturing | 3/03/2026 |
| metronidazole | Tablet, uncoated | 400 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 3/03/2026 |
| pioglitazone hydrochloride | Tablet, uncoated | 49.59 mg | Resolved | Available | Manufacturing | 3/03/2026 |
| pioglitazone hydrochloride | Tablet, uncoated | 33.06 mg | Resolved | Available | Manufacturing | 3/03/2026 |
| pioglitazone hydrochloride | Tablet, uncoated | 16.53 mg | Resolved | Available | Manufacturing | 3/03/2026 |
| cabergoline | Tablet, uncoated | 1 mg | Current | Limited Availability | Manufacturing | 3/03/2026 |
| stannous chloride dihydrate | Injection, powder for | 19.2 microgram/mL | Current | Limited Availability | Manufacturing | 3/03/2026 |
| milrinone | Injection, concentrated | 10 mg | Current | Unavailable | Manufacturing | 3/03/2026 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Resolved | Available | Manufacturing | 3/03/2026 |
| daptomycin | Injection, powder for | 500 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 3/03/2026 |
| chlorpromazine hydrochloride | Oral Liquid | 5 mg/mL | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 3/03/2026 |
| levothyroxine sodium | Tablet, uncoated | .075 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 3/03/2026 |
| Teriparatide | Injection, solution | .25 mg/mL | Current | Limited Availability | Manufacturing | 3/03/2026 |
| oseltamivir phosphate | Oral Liquid, powder for | 7.88 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 3/03/2026 |
| lanreotide acetate | Injection, solution | 133.33 mg | Resolved | Available | Manufacturing | 3/03/2026 |
| finasteride | Tablet, film coated | 1 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 3/03/2026 |
| sugammadex sodium | Injection, solution | 217.6 mg | Current | Unavailable | Manufacturing | 3/03/2026 |
| finasteride | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 3/03/2026 |
| doxorubicin hydrochloride | Injection | 2 mg/mL | Anticipated | Available | Manufacturing | 3/03/2026 |
| levothyroxine sodium | Tablet, uncoated | .1 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 3/03/2026 |
| dinoprostone | Gel | .6667 mg/g | Current | Unavailable | Manufacturing | 3/03/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Unavailable | Unexpected increase in consumer demand | 2/03/2026 |
| Somatropin | Injection, powder for | 5 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 2/03/2026 |
| human menopausal gonadotrophin | Injection, powder for | 1200 IU | Resolved | Available | Manufacturing | 2/03/2026 |
| human menopausal gonadotrophin | Injection, powder for | 600 IU | Resolved | Available | Manufacturing | 2/03/2026 |
| sodium valproate | Tablet, uncoated | 100 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 2/03/2026 |
| ropivacaine hydrochloride | Injection, solution | 400 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 2/03/2026 |
| sodium chloride | Injection, solution | .45 g | Current | Unavailable | Commercial Changes / Commercial viability | 2/03/2026 |
| amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil | Tablet, film coated | 13.9 mg~12.5 mg~40 mg | Anticipated | Available | Manufacturing | 2/03/2026 |
| mitomycin | Injection, powder for | 20 mg | Current | Limited Availability | Manufacturing | 2/03/2026 |
| estradiol | Drug delivery system, transdermal | 1.17 mg | Current | Limited Availability | Manufacturing | 2/03/2026 |
| estradiol | Drug delivery system, transdermal | .585 mg | Current | Unavailable | Manufacturing | 2/03/2026 |
| levothyroxine sodium | Tablet | 50 microgram | Current | Unavailable | Commercial Changes / Commercial viability | 2/03/2026 |
| bupivacaine hydrochloride | Injection, solution | 5 mg/mL | Anticipated | Available | Manufacturing | 2/03/2026 |
| desmopressin acetate | Spray, solution | 10 microgram/actuation | Current | Limited Availability | Manufacturing | 2/03/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 2/03/2026 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 2/03/2026 |
| doxepin hydrochloride | Capsule, hard | 28.25 mg | Current | Unavailable | Manufacturing | 2/03/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Anticipated | Available | Manufacturing | 2/03/2026 |
| rasagiline mesilate | Tablet | 1.56 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 2/03/2026 |
| ibandronate sodium | Tablet, film coated | 56.25 mg | Anticipated | Available | Manufacturing | 2/03/2026 |
| olopatadine hydrochloride | Eye Drops, solution | 1.11 mg/mL | Current | Emergency Supply Only | Unexpected increase in consumer demand | 2/03/2026 |
| ezetimibe~simvastatin | Tablet | 10 mg~20 mg | Current | Limited Availability | Manufacturing | 2/03/2026 |
| levothyroxine sodium | Tablet | 75 microgram | Current | Unavailable | Commercial Changes / Commercial viability | 2/03/2026 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Current | Limited Availability | Unexpected increase in consumer demand | 2/03/2026 |
| atomoxetine hydrochloride | Capsule, hard | 20.57 mg | Resolved | Available | Manufacturing | 2/03/2026 |
| flecainide acetate | Tablet, uncoated | 50 mg | Current | Unavailable | Manufacturing | 2/03/2026 |
| galantamine hydrobromide | Capsule, modified release | 20.512 mg | Resolved | Available | Unexpected increase in consumer demand | 2/03/2026 |
| lamotrigine | Tablet, chewable | 100 mg | Anticipated | Available | Manufacturing | 2/03/2026 |
March 02, 2026
March 06, 2026
March 05, 2026
March 04, 2026
March 03, 2026
March 02, 2026

